Fairvalue-Calculator Fairvalue-Calculator
EN DE

ICD Co (040910) Fair Value & Analysis

Technology · KR · Market cap 75.6B KRW

Price3,955 KRW
Fair Value6,542 KRW
Upside+65.4%
Quality95/100
Evidence: High Range 4,759 KRW – 8,325 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ICD Co (040910) currently trades at 3,955 KRW, while our model-based Fair Value estimate is 6,542 KRW — implying the stock looks roughly 65.4% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, South Korea.

Open the full interactive analysis →

Similar stocks

Hon Hai Precision Industry Co (HHPD) -36% Delta Electronics, Inc (2308) -80% Amphenol Corporation (APH) -56% Corning Incorporated (GLW) -86% Samsung Electro-Mechanics Co (009150) -83% Luxshare Precision Industry Co (002475) -69%

Frequently asked questions

Is ICD Co (040910) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 6,542 KRW versus a price of 3,955 KRW — about +65% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 040910?
Our 21-model fair value for ICD Co is 6,542 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 3,955 KRW.
What is the quality score of 040910?
ICD Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.